{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:55:38Z","timestamp":1790931338064,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2023YFC3605400"],"award-info":[{"award-number":["2023YFC3605400"]}]},{"name":"Science and Technology Innovation 2030 Major Projects","award":["2022ZD0211600"],"award-info":[{"award-number":["2022ZD0211600"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Beijing Nova Program"],"award-info":[{"award-number":["Beijing Nova Program"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00259-026-08085-w","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:39:01Z","timestamp":1784511541000},"page":"7489-7503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apolipoprotein E \u03b54 and type 2 diabetes cooperatively accelerate amyloid beta and tau neurodegeneration"],"prefix":"10.1007","volume":"53","author":[{"given":"Yaojing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-4218","authenticated-orcid":false,"given":"Zhanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"8085_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","volume":"42","author":"G Cheng","year":"2012","unstructured":"Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484\u201391. https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02758.x.","journal-title":"Intern Med J"},{"key":"8085_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","volume":"76","author":"J Li","year":"2011","unstructured":"Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485\u201391. https:\/\/doi.org\/10.1212\/WNL.0b013e318217e7a4.","journal-title":"Neurology"},{"key":"8085_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330. https:\/\/doi.org\/10.1038\/s41588-019-0358-2.","journal-title":"Nat Genet"},{"key":"8085_CR4","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2006;103:5644\u201351. https:\/\/doi.org\/10.1073\/pnas.0600549103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8085_CR5","doi-asserted-by":"publisher","first-page":"18700","DOI":"10.1073\/pnas.0508693102","volume":"102","author":"S Ye","year":"2005","unstructured":"Ye S, Huang Y, M\u00fcllendorff K, Dong L, Giedt G, Meng EC, et al. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci USA. 2005;102:18700\u20135. https:\/\/doi.org\/10.1073\/pnas.0508693102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8085_CR6","doi-asserted-by":"publisher","unstructured":"Mantik KEK, Kim S, Gu B, Moon S, Kwak HB, Park DH, et al. Repositioning of anti-diabetic drugs against dementia: insight from molecular perspectives to clinical trials. Int J Mol Sci. 2023;24:11450. https:\/\/doi.org\/10.3390\/ijms241411450","DOI":"10.3390\/ijms241411450"},{"key":"8085_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012;76:871\u201385. https:\/\/doi.org\/10.1016\/j.neuron.2012.11.020.","journal-title":"Neuron"},{"key":"8085_CR8","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3:89ra57. https:\/\/doi.org\/10.1126\/scitranslmed.3002156.","journal-title":"Sci Transl Med"},{"key":"8085_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.sjbs.2019.12.028","volume":"27","author":"RL Jayaraj","year":"2020","unstructured":"Jayaraj RL, Azimullah S, Beiram R. Diabetes as a risk factor for Alzheimer\u2019s disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci. 2020;27:736\u201350. https:\/\/doi.org\/10.1016\/j.sjbs.2019.12.028.","journal-title":"Saudi J Biol Sci"},{"key":"8085_CR10","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies - The Honolulu-Asia Aging Study. Diabetes. 2002;51:1256\u201362. https:\/\/doi.org\/10.2337\/diabetes.51.4.1256.","journal-title":"Diabetes"},{"key":"8085_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.sjbs.2019.12.028","volume":"27","author":"RL Jayaraj","year":"2020","unstructured":"Jayaraj RL, Azimullah S, Beiram R. Diabetes as a risk factor for Alzheimer\u2019s disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci. 2020;27:736\u201350. https:\/\/doi.org\/10.1016\/j.sjbs.2019.12.028.","journal-title":"Saudi J Biol Sci"},{"key":"8085_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/jad-160164","volume":"55","author":"LF Miranda","year":"2017","unstructured":"Miranda LF, Gomes KB, Tito PA, Silveira JN, Pianetti GA, Byrro RM, et al. Clinical response to donepezil in mild and moderate dementia: relationship to drug plasma concentration and CYP2D6 and APOE genetic polymorphisms. J Alzheimer\u2019s disease: JAD. 2017;55:539\u201349. https:\/\/doi.org\/10.3233\/jad-160164.","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"8085_CR13","doi-asserted-by":"publisher","first-page":"43701","DOI":"10.1038\/srep43701","volume":"7","author":"LA Johnson","year":"2017","unstructured":"Johnson LA, Torres ER, Impey S, Stevens JF, Raber J. Apolipoprotein E4 and insulin resistance interact to impair cognition and alter the epigenome and metabolome. Sci Rep. 2017;7:43701. https:\/\/doi.org\/10.1038\/srep43701.","journal-title":"Sci Rep"},{"key":"8085_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","volume":"75","author":"T Matsuzaki","year":"2010","unstructured":"Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764\u201370. https:\/\/doi.org\/10.1212\/WNL.0b013e3181eee25f.","journal-title":"Neurology"},{"key":"8085_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/brain\/awac354","volume":"146","author":"J van Arendonk","year":"2023","unstructured":"van Arendonk J, Neitzel J, Steketee RME, van Assema DME, Vrooman HA, Segbers M, et al. Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study. Brain. 2023;146:337\u201348. https:\/\/doi.org\/10.1093\/brain\/awac354.","journal-title":"Brain"},{"key":"8085_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/gtmb.2020.0130","volume":"25","author":"C Gao","year":"2021","unstructured":"Gao C, Fu X, Chu Q, Li J, Shu G. Relationship between the ApoE gene polymorphism and type 2 diabetes mellitus complications. Genetic Test Mol biomarkers. 2021;25:111\u20135. https:\/\/doi.org\/10.1089\/gtmb.2020.0130.","journal-title":"Genetic Test Mol biomarkers"},{"key":"8085_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ymgme.2010.03.008","volume":"100","author":"PG Anthopoulos","year":"2010","unstructured":"Anthopoulos PG, Hamodrakas SJ, Bagos PG. Apolipoprotein E polymorphisms and type 2 diabetes: a meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab. 2010;100:283\u201391. https:\/\/doi.org\/10.1016\/j.ymgme.2010.03.008.","journal-title":"Mol Genet Metab"},{"key":"8085_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.14336\/ad.2017.0715","volume":"9","author":"J Zhen","year":"2018","unstructured":"Zhen J, Lin T, Huang X, Zhang H, Dong S, Wu Y, et al. Association of ApoE genetic polymorphism and type 2 diabetes with cognition in non-demented aging chinese adults: a community based cross-sectional study. Aging disease. 2018;9:346\u201357. https:\/\/doi.org\/10.14336\/ad.2017.0715.","journal-title":"Aging disease"},{"key":"8085_CR19","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00125-009-1497-2","volume":"52","author":"GA Dore","year":"2009","unstructured":"Dore GA, Elias MF, Robbins MA, Elias PK, Nagy Z. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study. Diabetologia. 2009;52:2551\u201360. https:\/\/doi.org\/10.1007\/s00125-009-1497-2.","journal-title":"Diabetologia"},{"key":"8085_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/jad-160114","volume":"53","author":"W Li","year":"2016","unstructured":"Li W, Huang E. An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia. J Alzheimer\u2019s disease: JAD. 2016;53:393\u2013402. https:\/\/doi.org\/10.3233\/jad-160114.","journal-title":"J Alzheimer\u2019s disease: JAD"},{"key":"8085_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archneurol.2007.29","volume":"65","author":"F Irie","year":"2008","unstructured":"Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol. 2008;65:89\u201393. https:\/\/doi.org\/10.1001\/archneurol.2007.29.","journal-title":"Arch Neurol"},{"key":"8085_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, et al. Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J nuclear medicine: official publication Soc Nuclear Med. 2015;56:567\u201374. https:\/\/doi.org\/10.2967\/jnumed.114.148981.","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"key":"8085_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr., Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2017;13:205\u201316. https:\/\/doi.org\/10.1016\/j.jalz.2016.08.005.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"8085_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, et al. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s Dement. 2015;11:1\u2013e154. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003.","journal-title":"Alzheimer\u2019s Dement"},{"key":"8085_CR25","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","volume":"14","author":"M Navitsky","year":"2018","unstructured":"Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, et al. Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement. 2018;14:1565\u201371. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.1353.","journal-title":"Alzheimers Dement"},{"key":"8085_CR26","doi-asserted-by":"publisher","first-page":"e12454","DOI":"10.1002\/dad2.12454","volume":"15","author":"VL Villemagne","year":"2023","unstructured":"Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, et al. CenTauR: Toward a universal scale and masks for standardizing tau imaging studies. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2023;15:e12454. https:\/\/doi.org\/10.1002\/dad2.12454.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"8085_CR27","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1002\/alz.13908","volume":"20","author":"A Leuzy","year":"2024","unstructured":"Leuzy A, Raket LL, Villemagne VL, Klein G, Tonietto M, Olafson E, et al. Harmonizing tau positron emission tomography in Alzheimer\u2019s disease: The CenTauR scale and the joint propagation model. Alzheimer\u2019s Dement. 2024;20:5833\u201348. https:\/\/doi.org\/10.1002\/alz.13908.","journal-title":"Alzheimer\u2019s Dement"},{"key":"8085_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol. 2009;65:403\u201313.","journal-title":"Ann Neurol"},{"key":"8085_CR29","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H. Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791\u2013800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791.","journal-title":"Neurology"},{"key":"8085_CR30","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-beta pathway in alzheimer\u2019s disease. Mol Psychiatry. 2021;26:5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"key":"8085_CR31","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","volume":"56","author":"S Swarbrick","year":"2019","unstructured":"Swarbrick S, Wragg N, Ghosh S, Stolzing A. Systematic review of miRNA as biomarkers in alzheimer\u2019s disease. Mol Neurobiol. 2019;56:6156\u201367. https:\/\/doi.org\/10.1007\/s12035-019-1500-y.","journal-title":"Mol Neurobiol"},{"key":"8085_CR32","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.2337\/dc14-1683","volume":"37","author":"Y Chen","year":"2014","unstructured":"Chen Y, Liu Z, Zhang J, Xu K, Zhang S, Wei D, et al. Altered brain activation patterns under different working memory loads in patients with type 2 diabetes. Diabetes Care. 2014;37:3157\u201363. https:\/\/doi.org\/10.2337\/dc14-1683.","journal-title":"Diabetes Care"},{"key":"8085_CR33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2337\/db19-0233","volume":"68","author":"S Gao","year":"2019","unstructured":"Gao S, Chen Y, Sang F, Yang Y, Xia J, Li X, et al. White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes. Diabetes. 2019;68:2085\u201394. https:\/\/doi.org\/10.2337\/db19-0233.","journal-title":"Diabetes"},{"key":"8085_CR34","doi-asserted-by":"publisher","first-page":"111731","DOI":"10.1016\/j.diabres.2024.111731","volume":"213","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Z, Chen Y, Dang M, Chen K, Sang F, et al. Cerebellar gray matter and white matter damage among older adults with prediabetes. Diabetes Res Clin Pract. 2024;213:111731. https:\/\/doi.org\/10.1016\/j.diabres.2024.111731.","journal-title":"Diabetes Res Clin Pract"},{"key":"8085_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14:168\u201381. https:\/\/doi.org\/10.1038\/nrneurol.2017.185.","journal-title":"Nat Rev Neurol"},{"key":"8085_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","volume":"23","author":"FG De Felice","year":"2022","unstructured":"De Felice FG, Goncalves RA, Ferreira ST. Impaired insulin signalling and allostatic load in Alzheimer disease. Nat Rev Neurosci. 2022;23:215\u201330. https:\/\/doi.org\/10.1038\/s41583-022-00558-9.","journal-title":"Nat Rev Neurosci"},{"key":"8085_CR37","first-page":"e12220","volume":"13","author":"GE Ennis","year":"2021","unstructured":"Ennis GE, Koscik RL, Ma Y, Jonaitis EM, Van Hulle CA, Betthauser TJ, et al. Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer\u2019s disease in non-demented adults. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2021;13:e12220.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"8085_CR38","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1111\/ejn.15685","volume":"56","author":"OG Steele","year":"2022","unstructured":"Steele OG, Stuart AC, Minkley L, Shaw K, Bonnar O, Anderle S, et al. A multi-hit hypothesis for an APOE4-dependent pathophysiological state. Eur J Neurosci. 2022;56:5476\u2013515. https:\/\/doi.org\/10.1111\/ejn.15685.","journal-title":"Eur J Neurosci"},{"key":"8085_CR39","doi-asserted-by":"publisher","first-page":"104755","DOI":"10.1016\/j.nbd.2020.104755","volume":"137","author":"EM Rhea","year":"2020","unstructured":"Rhea EM, Raber J, Banks WA. ApoE and cerebral insulin: Trafficking, receptors, and resistance. Neurobiol Dis. 2020;137:104755. https:\/\/doi.org\/10.1016\/j.nbd.2020.104755.","journal-title":"Neurobiol Dis"},{"key":"8085_CR40","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","volume":"38","author":"L Wu","year":"2018","unstructured":"Wu L, Zhang X, Zhao L. Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for alzheimer\u2019s disease risk reduction and early intervention. J Neurosci. 2018;38:6665\u201381. https:\/\/doi.org\/10.1523\/JNEUROSCI.2262-17.2018.","journal-title":"J Neurosci"},{"key":"8085_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, et al. Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes. Neuron. 2017;96:115\u2013e295. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.003.","journal-title":"Neuron"},{"key":"8085_CR42","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3233\/JAD-159002","volume":"45","author":"A Claxton","year":"2015","unstructured":"Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, et al. Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage alzheimer\u2019s disease dementia. J Alzheimers Dis. 2015;45:1269\u201370. https:\/\/doi.org\/10.3233\/JAD-159002.","journal-title":"J Alzheimers Dis"},{"key":"8085_CR43","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.3390\/ijms26094209","volume":"26","author":"T Ponce-Lopez","year":"2025","unstructured":"Ponce-Lopez T. Peripheral inflammation and insulin resistance: their impact on blood\u2013brain barrier integrity and glia activation in Alzheimer\u2019s disease. Int J Mol Sci. 2025;26:4209.","journal-title":"Int J Mol Sci"},{"key":"8085_CR44","doi-asserted-by":"publisher","unstructured":"Dias D, Portugal CC, Relvas J, Socodato R. From genetics to neuroinflammation: the impact of ApoE4 on microglial function in alzheimer\u2019s disease. Cells. 2025;14:243. https:\/\/doi.org\/10.3390\/cells14040243","DOI":"10.3390\/cells14040243"},{"key":"8085_CR45","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1073\/pnas.1019164108","volume":"108","author":"X Fu","year":"2011","unstructured":"Fu X, Giavalisco P, Liu X, Catchpole G, Fu N, Ning ZB, et al. Rapid metabolic evolution in human prefrontal cortex. Proc Natl Acad Sci U S A. 2011;108:6181\u20136. https:\/\/doi.org\/10.1073\/pnas.1019164108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8085_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8:325\u201336. https:\/\/doi.org\/10.1016\/S2213-8587(19)30405-X.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8085_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pneurobio.2014.02.004","volume":"117","author":"AM Fjell","year":"2014","unstructured":"Fjell AM, McEvoy L, Holland D, Dale AM, Walhovd KB, Initiative ADN. What is normal in normal aging? Effects of aging, amyloid and Alzheimer\u2019s disease on the cerebral cortex and the hippocampus. Prog Neurobiol. 2014;117:20\u201340.","journal-title":"Prog Neurobiol"},{"key":"8085_CR48","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70:960\u20139. https:\/\/doi.org\/10.1097\/NEN.0b013e318232a379.","journal-title":"J Neuropathol Exp Neurol"},{"key":"8085_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fneur.2015.00247","volume":"6","author":"A Dorey","year":"2015","unstructured":"Dorey A, Perret-Liaudet A, Tholance Y, Fourier A, Quadrio I. Cerebrospinal fluid A\u03b240 improves the interpretation of A\u03b242 concentration for diagnosing alzheimer\u2019s disease. Front Neurol. 2015;6:247. https:\/\/doi.org\/10.3389\/fneur.2015.00247.","journal-title":"Front Neurol"},{"key":"8085_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, et al. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol neurodegeneration. 2017;12:63. https:\/\/doi.org\/10.1186\/s13024-017-0206-8.","journal-title":"Mol neurodegeneration"},{"key":"8085_CR51","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772\u201381. https:\/\/doi.org\/10.1001\/jama.2020.12134.","journal-title":"JAMA"},{"key":"8085_CR52","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1037\/neu0000177","volume":"29","author":"LE Oberlin","year":"2015","unstructured":"Oberlin LE, Manuck SB, Gianaros PJ, Ferrell RE, Muldoon MF, Jennings JR, et al. Blood pressure interacts with APOE \u03b54 to predict memory performance in a midlife sample. Neuropsychology. 2015;29:693\u2013702. https:\/\/doi.org\/10.1037\/neu0000177.","journal-title":"Neuropsychology"},{"key":"8085_CR53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1037\/0894-4105.19.1.28","volume":"19","author":"I Driscoll","year":"2005","unstructured":"Driscoll I, McDaniel MA, Guynn MJ. Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology. 2005;19:28\u201334. https:\/\/doi.org\/10.1037\/0894-4105.19.1.28.","journal-title":"Neuropsychology"},{"key":"8085_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/nyas.12807","volume":"1353","author":"A Moheet","year":"2015","unstructured":"Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60\u201371. https:\/\/doi.org\/10.1111\/nyas.12807.","journal-title":"Ann N Y Acad Sci"},{"key":"8085_CR55","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","volume":"35","author":"M Usenovic","year":"2015","unstructured":"Usenovic M, Niroomand S, Drolet RE, Yao L, Gaspar RC, Hatcher NG, et al. Internalized Tau oligomers cause neurodegeneration by inducing accumulation of pathogenic Tau in human neurons derived from induced pluripotent stem cells. J Neurosci. 2015;35:14234\u201350. https:\/\/doi.org\/10.1523\/JNEUROSCI.1523-15.2015.","journal-title":"J Neurosci"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-08085-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-08085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:32:11Z","timestamp":1790929931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-08085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8085"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-08085-w","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data used in this study were obtained from the ADNI. The ADNI study was approved by the Institutional Review Boards of all participating institutions. Written informed consent was obtained from all participants or their authorized representatives before participation, in accordance with the Declaration of Helsinki. No additional ethical approval was required for the present secondary analysis of de-identified ADNI data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}